Vascular endothelial cell growth factor antagonists and uses thereof
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- GENENTECH INC
- Publication Date
- 2005-03-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] This is a non-provisional application filed pursuant to 37 CFR 1.53(b). FIELD OF THE INVENTION
[0002] The present invention relates to vascular endothelial cell growth factor (VEGF) antagonists, to therapeutic compositions comprising the antagonists, and to methods of use of the antagonists for diagnostic and therapeutic purposes. In particular, the present invention relates to methods of treatment of stroke or edema using VEGF antagonists. BACKGROUND OF THE INVENTION
[0003] The two major cellular components of the vasculature are the endothelial and smooth muscle cells. The endothelial cells form the lining of the inner surface of all blood vessels, and constitute a nonthrombogenic interface between blood and tissue. In addition, endothelial cells are an important component for the development of new capillaries and blood vessels. Thus, endothelial cells proliferate during the angiogenesis, or neovascularization, associated with tumor growth and metastasis, as well as a vari...